Clinical trials
Phase 3 Marijuana Abuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 9 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Completed | 8 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Apurano Pharmaceuticals GmbH | 8 |
| McMaster University | 3 |
| Assaf-Harofeh Medical Center | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Butler Hospital | 1 |
| Denise Walker | 1 |
| Fenix Innovation Group | 1 |
| Hadassah Medical Organization | 1 |
| Harley Street (CPC) Limited | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Marijuana Abuse | 26 |
| Chronic Pain | 9 |
| Agnosia | 8 |
| Pain | 8 |
| Somatoform Disorders | 8 |
| Neuralgia | 4 |
| Peripheral Nervous System Diseases | 4 |
| Agoraphobia | 2 |
| Anxiety Disorders | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.